Meningiomas and hormonal receptors. Immunohistochemical study in typical and non-typical tumors

Arquivos de Neuro-Psiquiatria

Volumn 56, Issue 2, 1998, Pages 193-199

  Hilbig, Arlete ^a,b   Barbosa Coutinho, Lígia Maria ^a,b  

^a Fund Faculdade Fed Cie Medicas P   (Brazil)

^b Department of Pathology ^*  (Brazil)

Author keywords

Estrogen receptor; Immunohistochemistry; Meningioma; Progesterone receptor

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMISTRY; CHILD; FEMALE; HUMAN; IMMUNOLOGY; MALE; MENINGIOMA; MIDDLE AGED; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0032091140     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X1998000200005     Document Type: Article

References (30)

1. Russell DS, Rubinstein LJ. Pathology of tumors of the nervous system. 5.Ed London: Edward Arnold, 1989.
2. Bickerstaff ER, Small JM, Guest IA. The relapsing course of certain meningiomas in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry 1958:21:89-91.
3. Burns PE, Jha N, Bain GO. Association of breast cancer with meningioma. Cancer 1986;58:1537-1539.
4. Shoenberg BS, Christine BW, Whisnant JP. Nervous system neoplasm and primary malignancies of other sites: the unique association between meningioma and breast cancer. Neurology 1975;25 705-712.
5. Blankenstein MA, Berns PMJJ, Mulder E et al. Search for estrogen receptors in human meningioma tissue sections with a monoclonal antibody against the human estrogen receptor Cancer Res 1986;46(Suppl):4268s-4270s.
6. Cahill DW, Bashirelahi N, Solomon LW et al. Estrogen and progesterone receptors in meningiomas J Neurosurg 1984;60.985-993.
7. Carrol RS, Glowacka KD, Black PM Progesterone receptor expression in meningiomas. Cancer Res 1993;53:1312-1316
8. Donnel MS, Meyer GA, Donegan WL. Estrogen-receptor protein in intracranial meningiomas. J Neurosurg 1979,50:499-502.
9. Hsu DW, Efird JT, Hedley-Whyte ET Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 1997;86:113-120
10. Ironside JW, Battersby RDE, Dangerfield VJ et al Cryostat section assay of oestrogen and progesterone receptors in meningiomas: a clinicopathological study. J Clin Pathol 1986;39:44-50.
11. Jay JR, MacLaughlin DT, Riley KR, Martuza R. Modulation of meningioma cell growth by sex steroid hormones in vitro. J Neurosurg 1985;62:757-762.
12. Koper JW, Foekens JA, Braakman R, Lamberts SW Effects of progesterone on the iesponse to epidermal growth factor and other growth factors in cultured human meningioma cells Cancer Res 1990;50.2604-2607
13. Kostron H, Daxenbichler G, Maier H Steroidrezeptoren und atypische Histologie als prognostische Parameter bei Meningiomen Wiener Klin Wchsrft 1990,18:525-528
14. Markwalder TM, Zava DT, Goldhirsch A, Markwalder RV. Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features. Surg Neurol 1983;20 42-47.
15. Whittle IR, Foo MS, Besser M, Vanderfield GK. Progesterone and oestrogen receptors in meningiomas: biochemical and clinicopathological considerations Aust N Z J Surg 1984;54:325-330.
16. Halper J, Colvard DS, Scheithauer BW et al. Estrogen and progesterone receptors in meningiomas: comparison of nuclear binding, dextran-coated charcoal and immunoperoxidase staining assays Neurosurgery 1989;25:546-553,
17. Perrot-Applanat M, Groyer-Picard MT, Kujas M. Immunocytochemical study of progesterone receptor in human meningioma. Acta Neurochir (Wien) 1992;115 20-30.
18. Tesch M, Shawwa A, Henderson AR. Immunohistochemical determination of estrogen and progesterone receptor status in breast cancel. Am J Clin Pathol 1993,99:8-12
19. Maier H, Ofner D, Hittmair A et al. Classical, atypical and anaplastic meningiomas: three histopathological subtypes of clinical relevance. J Neurosurg 1992;77:616-623.
20. Adegbite AB, Moe IK, Pain KWE et al The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 1983,58:51-56
21. Böker DK, Meuier H, Gullotta F. Recurring intracranial meningiomas: evaluation of some factors predisposing for tumor recurrence. J Neurosurg Sci 1985,29:11-17
22. May PL, Broome JC, Path MRC et al The prediction of recurrence in meningiomas J Neurosurg 1989,71:347-351.
23. Fogelholm R, Uutela T, Munos K Epidemiology of central nervous system neoplasms a regional survey in central Finland. Acta Neurol Scand 1984,69.129-136.
24. Hilbig A, Barbosa-Coutinho LM. Meningiomas: aspectos histopatológicos e recidiva Arq Neuropsiquiatr 1997;55:431-437.
25. Jaaskelainen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy and outcome. Surg Neurol 1986,25:233-242
26. Adams EF, Schrell U, Honegger J et al Effects of steroids and EGF on the growth of meningiomas. Acta Endocrinol 1989;120(Suppl) 257-260.
27. Piquet J, Cerda M, Lluch A et al. Correlation of female steroid hormone receptors with histologic features in meningiomas Acta Neurochir (Wien) 1991,110:38-43
28. Brandis A, Mirzai S, Tatagiba M et al. Immunohistochemical detection of female sex hormone receptors in meningiomas correlation with clinical and histological features Neurosurgery 1993,33:212-218.
29. Grunberg SM, Weiss MH, Spitz I et al Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 1991;74.861-866.
30. Lamberts SWJ, Tanghe HL, Avazaat CJJ et al. Mifepristone (RU 486) treatment of meningiomas. J Neurol Neurosurg Psychiatry 1992;55:486-490